Multiple-dose Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis

NCT02559934 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

G&E Herbal Biotechnology Co., LTD